HOME >> BIOLOGY >> NEWS
Common nutrients fed to pregnant mice altered their offspring's coat color

DURHAM, N.C. A startling scientific discovery about nutrition demonstrates that we are more than what we eat: we are likely what our mothers ate, too, according to scientists at the Duke Comprehensive Cancer Center.

In a study of nutrition's effects on development, the scientists showed they could change the coat color of baby mice simply by feeding their mothers four common nutritional supplements before and during pregnancy and lactation. Moreover, these four supplements lowered the offspring's susceptibility to obesity, diabetes and cancer.

Results of the study are published in and featured on the cover of the Aug. 1, 2003, issue of Molecular and Cellular Biology.

"We have long known that maternal nutrition profoundly impacts disease susceptibility in their offspring, but we never understood the cause-and-effect link," said Randy Jirtle, Ph.D., professor of radiation oncology at Duke and senior investigator of the study. "For the first time ever, we have shown precisely how nutritional supplementation to the mother can permanently alter gene expression in her offspring without altering the genes themselves."

In the Duke experiments, pregnant mice that received dietary supplements with vitamin B12, folic acid, choline and betaine (from sugar beets) gave birth to babies predominantly with brown coats. In contrast, pregnant mice that did not receive the nutritional supplements gave birth predominantly to mice with yellow coats. The non-supplemented mothers were not deficient in these nutrients.

A study of the cellular differences between the groups of baby mice showed that the extra nutrients reduced the expression of a specific gene, called Agouti, to cause the coat color change. Yet the Agouti gene itself remained unchanged.

Just how the babies' coat colors changed without their Agouti gene being altered is the most exciting part of their research, said Jirtle. The mechanism that enabled this permanent color change
'"/>

Contact: Becky Levine
levin005@mc.duke.edu
919-684-4148
Duke University Medical Center
1-Aug-2003


Page: 1 2 3 4

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common treatment for depression is safe and effective for Alzheimers patients
10. Common gene variant increases risk of atherosclerosis
11. Common thyroid cancer gene mutation found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/16/2019)... , ... April 16, 2019 , ... ... featured speakers for two signature events: The 2019 ISPE Biopharmaceutical Manufacturing Conference ... on 20–21 June. Taking place in one of the most influential bio hubs, ...
(Date:4/12/2019)... ... April 12, 2019 , ... Gnubiotics ... complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal and ... Register and commercial launch of its first-in class microbiome modulating prebiotic GNU100, for ...
(Date:4/5/2019)... ... April 04, 2019 , ... PI’s ... providing 0.05 microns and 0.005 microns resolution, respectively. The new design allows for ... available, from fast DC-servo motors with linear encoders and low-friction ball-screws to simple ...
Breaking Biology News(10 mins):
(Date:4/15/2019)... , ... April 15, 2019 , ... ... completed construction of a $2 million bench plant expansion to increase production of ... step in the design and construction of Sirrus’ full-scale production facility, which is ...
(Date:4/9/2019)... (PRWEB) , ... April 09, 2019 , ... ... firm focused on increasing the capacity of life sciences organizations to accelerate innovation ... Cloud Assurance platform in the past 12 months. , USDM’s Cloud ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
Breaking Biology Technology:
Cached News: